Published June 3 2021
Solutions: Extend trial to 6 months before concluding inefficacy (some benefits take longer), increase dosing within safe ranges if using lower end, switch peptides (try Cerebrolysin if using BPC-157, or vice versa), add comprehensive eye exam to rule out progression versus peptide failure, consider peptides preventing worsening rather than producing improvement, discontinue if truly no benefit after 6 months rigorous trial
Similar to other GLP-1 drugs, CagriSema had mild to moderate side effects, which were mainly gastrointestinal (including nausea, vomiting, diarrhea, and constipation) and diminished over time
Homocysteine is a naturally occurring amino acid produced during the metabolism of methionine, an essential amino acid obtained from dietary protein
Yeah probably But youre trading cheap and questionable for verified and medically supervised (and for those hell bent on ordering on the gray market they still can) Thats a win in my book Because as popular as the compounds are getting people werent going to stop taking them This is a huge win